A Search Service for Abbreviation / Long Form

■ 関連PubMed/MEDLINE情報

[関連PubMed/MEDLINE情報]
合計出現文献数: 374
[表示件数]
100 件 (発表年降順)
100 件 (発表年昇順)
全件
[1ページの表示件数]
ページ移動
/ ページ
略語 : Sal B
展開形 : Salvianolic acid B
  
No. 発表年 題目 共起略語
2023 Safety, tolerance, and pharmacokinetics of salvianolic acid B in healthy Chinese volunteers: A randomized, double-blind, placebo-controlled phase 1 clinical trial. ---
2023 Salvia Miltiorrhiza Extract Prevents the Occurrence of Early Atherosclerosis in Apoe -/- Mice Via TLR4/ NF-Κb Pathway. CK, DSS, HDL-C, IL-6, LDH, LDL-C, NF-kappaB, PAL, RC, SABP, Sal-A, SM, TAK1, TC, TG, TLR4, TNF-alpha
2023 Salvianolic acid B as a potent nano-agent for enhanced ALA-PDT of oral cancer and leukoplakia cells. ALA, PDT, SOSG
2023 Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro. HSFs, HTSs
2023 Salvianolic acid B promotes the invasion and migration of HO-induced HTR-8/Svneo trophoblast cells by upregulating matrix metalloproteinase-9 the phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B pathway. MMP-9, MTT, PE, PI3K, RT-qPCR, TdT
2023 Salvianolic Acid B Regulates Oxidative Stress, Autophagy and Apoptosis against Cyclophosphamide-Induced Hepatic Injury in Nile Tilapia (Oreochromis niloticus). ---
2023 [Protective mechanism of salvianolic acid B on blood vessels]. AS, ERS, HG, PAD, VSMC
2022 Attenuation of Oxidative Stress-Induced Cell Apoptosis and Pyroptosis in RSC96 Cells by Salvianolic Acid B. IL, PARP, ROS
2022 Changes in Cardiac Function During the Development of Uremic Cardiomyopathy and the Effect of Salvianolic Acid B Administration in a Rat Model. CKD, CMME, IVPG, UC
10  2022 Combining Network Pharmacology with Experimental Validation to Elucidate the Mechanism of Salvianolic Acid B in Treating Diabetic Peripheral Neuropathy. DPN
11  2022 Components of Salvia miltiorrhiza and Panax notoginseng Protect Pericytes Against OGD/R-Induced Injury via Regulating the PI3K/AKT/mTOR and JNK/ERK/P38 Signaling Pathways. CCK-8, OGD/R, PNS, SAL, Sal D
12  2022 Effect of astragaloside IV and salvianolic acid B on antioxidant stress and vascular endothelial protection in the treatment of atherosclerosis based on metabonomics. AS, AS-IV
13  2022 Effects and Mechanism of Salvianolic Acid B on the Injury of Human Renal Tubular Epithelial Cells Induced by Iopromide. CIN, ERS, ROS
14  2022 Effects of salvianolic acid A and salvianolic acid B in renal interstitial fibrosis via PDGF-C/PDGFR-alpha signaling pathway. CKD, ERS, ESRD, RIF, Sal A
15  2022 Functional pleiotropism, diversity, and redundancy of Salvia miltiorrhiza Bunge JAZ family proteins in jasmonate-induced tanshinone and phenolic acid biosynthesis. JA, JAZ, LCI, qRT-PCR
16  2022 Identification of core genes associated with the anti-atherosclerotic effects of Salvianolic acid B and immune cell infiltration characteristics using bioinformatics analysis. AS, ASCVD, DEGs, miRNAs, ROC, ssGSEA, TFs, WGCNA
17  2022 Inhalation of Salvianolic Acid B Prevents Fine Particulate Matter-Induced Acute Airway Inflammation and Oxidative Stress by Downregulating the LTR4/MyD88/NLRP3 Pathway. KC, MyD88, NLRP3, TLR4, TRAF-6
18  2022 Inhibition of chemically and mechanically activated Piezo1 channels as a mechanism for ameliorating atherosclerosis with salvianolic acid B. BMDMs, MLECs, oxLDL
19  2022 Pharmacological manipulation of Ezh2 with salvianolic acid B results in tumor vascular normalization and synergizes with cisplatin and T cell-mediated immunotherapy. ECs, EZH2, TME
20  2022 Preparation and Synergistic Effect of Biomimetic Poly(lactic acid)/Graphene Oxide Composite Scaffolds Loaded with Dual Drugs. GO, PLA
21  2022 Protective effects of Salvianolic acid B on rat ferroptosis in myocardial infarction through upregulating the Nrf2 signaling pathway. DFO, Fer-1, MI, Nrf2, TCM
22  2022 Salvianolic acid B activates chondrocytes autophagy and reduces chondrocyte apoptosis in obese mice via the KCNQ1OT1/miR-128-3p/SIRT1 signaling pathways. HFD, NCD, OA, PA
23  2022 Salvianolic acid B alleviates comorbid pain in depression induced by chronic restraint stress through inhibiting GABAergic neuron excitation via an ERK-CREB-BDNF axis-dependent mechanism. CRS
24  2022 Salvianolic acid B alleviates diabetic endothelial and mitochondrial dysfunction by down-regulating apoptosis and mitophagy of endothelial cells. AB, Bax, Bcl-2, CCCP, HG, HUVECs, PINK1
25  2022 Salvianolic Acid B Alleviates Limb Ischemia in Mice via Promoting SIRT1/PI3K/AKT Pathway-Mediated M2 Macrophage Polarization. LSCI, PAD
26  2022 Salvianolic Acid B Alleviates Myocardial Ischemia Injury by Suppressing NLRP3 Inflammasome Activation via SIRT1-AMPK-PGC-1alpha Signaling Pathway. MI, MMP
27  2022 Salvianolic acid B alleviates neurological injury by upregulating stanniocalcin 1 expression. HUVECs, MCAO, mTOR, STC1, TTC, VEGFR2
28  2022 Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice. ALT, AST, CD36, FASN, FFA, IL-1beta, IL-6, NAFLD, PPARgamma, SCD1, TC, TG, TNF-alpha
29  2022 Salvianolic Acid B Attenuates Iopromide-Induced Renal Tubular Epithelial Cell Injury by Inhibiting the TLR4/NF-kappaB/NLRP3 Signaling Pathway. DeltaPsim, PC-AKI
30  2022 Salvianolic acid B attenuates membranous nephropathy by activating renal autophagy via microRNA-145-5p/phosphatidylinositol 3-kinase/AKT pathway. HMCs, LC3, MN, PI3K
31  2022 Salvianolic acid B attenuates the inflammatory response in atherosclerosis by regulating MAPKs/ NF-kappaB signaling pathways in LDLR-/- mice and RAW264.7 cells. HFD, LPS, ox-LDL
32  2022 Salvianolic acid B combined with bone marrow mesenchymal stem cells piggybacked on HAMA hydrogel re-transplantation improves intervertebral disc degeneration. BMSCs
33  2022 Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis. IPF, LL, Sal B-DPI
34  2022 Salvianolic acid B exerts an anti-hepatocellular carcinoma effect by regulating the Hippo/YAP pathway and promoting pSmad3L to pSmad3C simultaneously. HCC
35  2022 Salvianolic acid B from Salvia miltiorrhiza bunge: A potential antitumor agent. ---
36  2022 Salvianolic acid B improves the survival rate, acute kidney dysfunction, inflammation and NETosis-mediated antibacterial action in a crush syndrome rat model. CS, NETs
37  2022 Salvianolic acid B inhibits autophagy and activation of hepatic stellate cells induced by TGF-beta1 by downregulating the MAPK pathway. 3-MA, CQ, HSCs, RAPA, TGF-beta1
38  2022 Salvianolic acid B inhibits myocardial I/R-induced ROS generation and cell apoptosis by regulating the TRIM8/GPX1 pathway. GPX1, I/R, MDA, ROS, SOD, TRIM
39  2022 Salvianolic acid B inhibits RAW264.7 cell polarization towards the M1 phenotype by inhibiting NF-kappaB and Akt/mTOR pathway activation. Arg-1, IL-10, IL-6, iNOS, LPS, NF-kappaB, TNF-alpha
40  2022 Salvianolic acid B inhibits the progression of liver fibrosis in rats via modulation of the Hedgehog signaling pathway. GLI1, Hh, PTCH1, Shh, Smo
41  2022 Salvianolic Acid B Protects Cardiomyocytes from Ischemia/Reperfusion Injury by Mediating circTRRAP/miR-214-3p/SOX6 Axis. 3'UTR, CCK-8, circRNAs, I/R, LDH, MDA, SOD
42  2022 Salvianolic Acid B Reduces the Inflammation of Fat Grafts by Inhibiting the NF-Kb Signalling Pathway in Macrophages. ---
43  2022 Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells. MMP-9, RT-PCR
44  2022 Salvianolic Acid B Suppresses ER Stress-Induced NLRP3 Inflammasome and Pyroptosis via the AMPK/FoxO4 and Syndecan-4/Rac1 Signaling Pathways in Human Endothelial Progenitor Cells. BM-EPCs, ER, MMP, ROS
45  2022 Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-kappaB signaling pathway via miR-6499-3p/LncRNA-ROR. CCK-8, HSC, LncRNA-ROR, miRNAs, qRT-PCR
46  2022 Salvianolic Acid B Suppresses Non-Small-Cell Lung Cancer Metastasis through PKM2-Independent Metabolic Reprogramming. ECAR, EMT, NSCLC, OCR
47  2022 Salvianolic acid B, a new type I IRE1 kinase inhibitor, abrogates AngII-induced angiogenesis by interacting with IRE1 in its active conformation. Ang II
48  2022 Salvianolic acidB acts against non‑small cell lung cancer A549 cells via inactivation of the MAPK and Smad2/3 signaling pathways. EMT, NSCLC, WB
49  2022 SmJAZ4 interacts with SmMYB111 or SmMYC2 to inhibit the synthesis of phenolic acids in Salvia miltiorrhiza. JA
50  2022 Therapeutic Effects of Salvianolic Acid B on Angiotensin II-Induced Atrial Fibrosis by Regulating Atrium Metabolism via Targeting AMPK/FoxO1/miR-148a-3p Axis. AMPK, Ang II, FBs, ROS
51  2022 To Analyze the Mechanism of SalB Regulating SIRT1 to Inhibit NLRP3 and Its Ameliorative Effect on Tubulogastric Junction Tumor Lesions Complicated with Myocardial Injury. AMPKalpha, LDH, NLRP3, P-AMPK alpha, PGC-1alpha, ROS
52  2022 Transcription Factor SmSPL2 Inhibits the Accumulation of Salvianolic Acid B and Influences Root Architecture. SPL
53  2022 [Preparation of salvianolic acid B, tanshinone Ⅱ_A, and glycyrrhetinic acid lipid emulsion and its protective effect against acute liver injury induced by acetaminophen]. GA
54  2021 Alleviatory effects of Danshen, Salvianolic acid A and Salvianolic acid B on PC12 neuronal cells and Drosophila melanogaster model of Alzheimer's disease. AD, DWE, REP, Sal A, UPLC
55  2021 Compound Danshen Dripping Pill ameliorates post ischemic myocardial inflammation through synergistically regulating MAPK, PI3K/AKT and PPAR signaling pathways. CDDP, NGR1, Tan IIA
56  2021 Dissection of the potential anti-diabetes mechanism of salvianolic acid B by metabolite profiling and network pharmacology. ---
57  2021 Effect of main ingredients of Danhong Injection against oxidative stress induced autophagy injury via miR-19a/SIRT1 pathway in endothelial cells. CVD, DHI, DSS, HSYA, HUVECs
58  2021 Effects of Salvianolic acid B on RNA expression and co-expression network of lncRNAs in brown adipose tissue of obese mice. BAT, GO
59  2021 Evaluation of Wound Healing Activity of Salvianolic Acid B on In Vitro Experimental Model. ---
60  2021 Extracts from Chinese herbs with anti-amyloid and neuroprotective activities. Tan IIA
61  2021 Ginsenoside Rb1, salvianolic acid B and their combination modulate gut microbiota and improve glucolipid metabolism in high-fat diet induced obese mice. LEfSe, Rb1SalB
62  2021 Intraventricular pressure gradients change during the development of left ventricular hypertrophy: Effect of salvianolic acid B and beta-blocker. ---
63  2021 Myocardial protective effect and transcriptome profiling of Naoxintong on cardiomyopathy in zebrafish. NXT, PF, SV-BA, TCM, TFD
64  2021 Omics and Transgenic Analyses Reveal that Salvianolic Acid B Exhibits its Anti-Inflammatory Effects through Inhibiting the Mincle-Syk-Related Pathway in Macrophages. LPS
65  2021 Protective Effects of Sal B on Oxidative Stress-Induced Aging by Regulating the Keap1/Nrf2 Signaling Pathway in Zebrafish. ---
66  2021 R2R3-MYB Transcription Factor SmMYB52 Positively Regulates Biosynthesis of Salvianolic Acid B and Inhibits Root Growth in Salvia miltiorrhiza. IAA, JA, qRT-PCR
67  2021 Salvianolic acid B ameliorates vascular endothelial dysfunction through influencing a bone morphogenetic protein 4-ROS cycle in diabetic mice. BMP4, EDRs
68  2021 Salvianolic acid B and ferulic acid synergistically promote angiogenesis in HUVECs and zebrafish via regulating VEGF signaling. FA, GXNT, MTT
69  2021 Salvianolic acid B attenuated cisplatin-induced cardiac injury and oxidative stress via modulating Nrf2 signal pathway. Nrf2
70  2021 Salvianolic acid B attenuates oxidative stress-induced injuries in enterocytes by activating Akt/GSK3beta signaling and preserving mitochondrial function. OS
71  2021 Salvianolic acid B improves autophagic dysfunction and decreases the apoptosis of cholesterol crystal‑induced macrophages via inhibiting the Akt/mTOR signaling pathway. AS, CHCs
72  2021 Salvianolic acid B protects against acute and chronic liver injury by inhibiting Smad2C/L phosphorylation. HO-1, Nrf2
73  2021 Salvianolic Acid B Protects Against Fatty Acid-Induced Renal Tubular Injury via Inhibition of Endoplasmic Reticulum Stress. ER, HFD, HFD, SFA
74  2021 Salvianolic acid B protects against MPP+-induced neuronal injury via repressing oxidative stress and restoring mitochondrial function. AMPK, IL-1beta, ROS
75  2021 Salvianolic acid B suppresses EMT and apoptosis to lessen drug resistance through AKT/mTOR in gastric cancer cells. DDP
76  2021 Salvianolic acid-B improves fat graft survival by promoting proliferation and adipogenesis. hADSCs
77  2021 Salvianolic acidB inhibits myofibroblast differentiation and extracellular matrix accumulation in nasal polyp fibroblasts via the TGF-beta1 signaling pathway. alpha-SMA, ECM, NPF
78  2021 Traditional Chinese Medicine Monomers: Novel Strategy for Endogenous Neural Stem Cells Activation After Stroke. ART, AST, BDNF, CNS, GB, HO-1, ICA, Nrf2, NSCs, RES, Shh, TCMs
79  2021 Transcription factor SmSPL7 promotes anthocyanin accumulation and negatively regulates phenolic acid biosynthesis in Salvia miltiorrhiza. SPL
80  2021 [Salvianolic acid B and its magnesium salt inhibit SARS-CoV-2 infection of Vero-E6 cells by blocking spike protein-mediated membrane fusion]. 6HB, TCM
81  2021 [Salvianolic acid B promotes the proliferation, migration and osteogenic differentiation of human gingival mesenchymal stem cells by activating the PI3K/AKT pathway]. ALP, hGMSCs
82  2020 A high-throughput and untargeted lipidomics approach reveals new mechanistic insight and the effects of salvianolic acid B on the metabolic profiles in coronary heart disease rats using ultra-performance liquid chromatography with mass spectrometry. CHD, UPLC/MS
83  2020 Andrade-Oliveira Salvianolic Acid B Modulates Caspase-1-Mediated Pyroptosis in Renal Ischemia-Reperfusion Injury via Nrf2 Pathway. AKI, GSDMD, I/R, IL, NLRP3, Nrf2
84  2020 Effect of salvianolic acid B on new bone formation in the orthopedically expanded suture. ---
85  2020 Effects of salvianolate lyophilized injection combined with Xueshuantong injection in regulation of BBB function in a co-culture model of endothelial cells and pericytes. BM, NR1, OGD/R, SLI, TJs, XST
86  2020 Effects of salvianolic acid B on liver fibrosis: A protocol for systematic review and meta analysis. CBM, CNKI
87  2020 Immunomodulatory effects of Salvianolic acid B in a spontaneous abortion mouse model. ---
88  2020 Mechanisms underlying the improvement of preeclampsia through salvianolic acid B-regulated miRNA-155/CXCR4. SBP
89  2020 MMP9 inhibition increases autophagic flux in chronic heart failure. AMPK, CHF, ECM, LVEDP, MI, MMP-9, mTOR
90  2020 Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage. ROS
91  2020 Salvia bowleyana Dunn root is a novel source of salvianolic acid B and displays antitumor effects against gastric cancer cells. ---
92  2020 Salvianolic acid B activates Wnt/beta-catenin signaling following spinal cord injury. SCI, TUNEL
93  2020 Salvianolic acid B alleviates myocardial ischemic injury by promoting mitophagy and inhibiting activation of the NLRP3 inflammasome. ISO, NLRP3, ROS
94  2020 Salvianolic acid B attenuates epithelial-mesenchymal transition in renal fibrosis rats through activating Sirt1-mediated autophagy. alpha-SMA, EMT, FN, TGF-beta
95  2020 Salvianolic acid B attenuates renal interstitial fibrosis by regulating the HPSE/SDC1 axis. ---
96  2020 Salvianolic acid B decreases interleukin-1beta-induced colitis recurrence in mice. IBD, IL-1beta, MLCK, TJ
97  2020 Salvianolic acid B improved insulin resistance through suppression of hepatic ER stress in ob/ob mice. ER
98  2020 Salvianolic Acid B Improves Chronic Mild Stress-Induced Depressive Behaviors in Rats: Involvement of AMPK/SIRT1 Signaling Pathway. 4-HNE, CAT, CHOP, CMS, ER, GRP78, HO-1, IL-1beta, IL-6, MDA, NF-kappaB, TNF-alpha
99  2020 Salvianolic Acid B improves cognitive impairment by inhibiting neuroinflammation and decreasing Abeta level in Porphyromonas gingivalis-infected mice. AD, P. gingivalis
100  2020 Salvianolic acid B improves myocardial function in diabetic cardiomyopathy by suppressing IGFBP3. Akt, DCM, IGFBP3, STZ, VEGF